Colorectal cancer screening completion: An examination of differences by screening modality

[1]  Tina Fan,et al.  Screening for Colorectal Cancer. , 2021, American family physician.

[2]  Jennifer S. Lin,et al.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2021, JAMA.

[3]  N. Dowling,et al.  Vital Signs: Colorectal Cancer Screening Test Use — United States, 2018 , 2020, MMWR. Morbidity and mortality weekly report.

[4]  T. Richards,et al.  Use of Colorectal Cancer Screening Tests by State , 2018, Preventing chronic disease.

[5]  C. Flowers,et al.  Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.

[6]  S. Fedewa,et al.  Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage. , 2018, Preventive medicine.

[7]  Jasmin A. Tiro,et al.  Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial , 2017, JAMA.

[8]  Patrick M. Wilson,et al.  Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening , 2017, Mayo Clinic proceedings.

[9]  M. Coombes,et al.  Longitudinal adherence to colorectal cancer screening guidelines. , 2016, The American journal of managed care.

[10]  Alison R. T. Brenner,et al.  Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years , 2016, The American Journal of Gastroenterology.

[11]  C. Klabunde,et al.  Vital Signs: Colorectal Cancer Screening Test Use — United States, 2012 , 2013, MMWR. Morbidity and mortality weekly report.

[12]  B. Yawn,et al.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. , 2012, Mayo Clinic proceedings.

[13]  B. Yawn,et al.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. , 2012, Mayo Clinic proceedings.

[14]  Rocca,et al.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. , 2011, American journal of epidemiology.

[15]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[16]  John P Klein,et al.  Analyzing survival curves at a fixed point in time , 2007, Statistics in medicine.

[17]  Helen I Meissner,et al.  Examination of population-wide trends in barriers to cancer screening from a diffusion of innovation perspective (1987-2000). , 2004, Preventive medicine.

[18]  R. Luckmann,et al.  Healthcare system factors and colorectal cancer screening. , 2002, American journal of preventive medicine.

[19]  S. Vernon,et al.  Participation in colorectal cancer screening: a review. , 1997, Journal of the National Cancer Institute.

[20]  Elizabeth M. Webber,et al.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.

[21]  Thomas E Novotny,et al.  US Department of Health and Human Services: a need for global health leadership in preparedness and health diplomacy. , 2006, American journal of public health.

[22]  Michael J Thun,et al.  Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. , 2003, Preventive medicine.

[23]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.